Solopharm got the GMP certificate!

On December 27, 2017 pharmaceutical company Solopharm obtained a certificate of compliance with the requirements of the rules of good manufacturing practice (GMP), thereby confirming the high level of the production system of the enterprise, which fully complies with the current legislation of the Russian Federation. The assessment, as part of an unplanned licensing audit, was carried out by the Ministry of Industry and Trade of the Russian Federation. All Solopharm manufacturing processes and procedures were certified for compliance with GMP requirements: sterile and non-sterile dosage forms, biological medicinal products, and the production of pharmaceutical substances. "GMP Certificate is an important document for us, as for the pharmaceutical company. It will allow us to increase consumer confidence, to gain advantages when participating in competitive selection procedures for suppliers, to start export to the CIS and foreign countries, which is an important factor for further growth and development of the enterprise, "says Solopharm's Operations Director, Tatyana Pypina. The rapid pace of development of the pharmaceutical industry requires companies not only to effectively conduct business, but also to strictly adhere to quality standards. The GMP certificate will allow Solopharm to become even stronger in the Russian and international markets of the pharmaceutical industry!